lung cancer (amsterdam, netherlands) | Journament

Journal Ranking

#958 / 33,952
📊 Below Average
Overall Score
41.2/100
Score Breakdown
Engagement
30
Accessibility
35
Timeliness
50
Diversity
30
Innovation
40
Community Impact
35
Ethics & Transparency
0
Content Quality
0
Editorial Diversity
0
Publication Regularity
0
Geographic Reach
0
Updated 2 days ago

lung cancer (amsterdam, netherlands)

Login or register to claim ownership or editorship of this journal.
Quality Widget - Embed on Your Website

Display your journal's quality scores on your website with our beautiful, self-contained widget. Choose between two embedding methods below.

One-Line JavaScript Embed (Recommended):
Advantages:
  • ✅ Simpler integration (just one line of code)
  • ✅ Better SEO (content is in same DOM)
  • ✅ No iframe limitations
  • ✅ Fully self-contained (no dependencies)
  • ✅ Works on any website regardless of CSS framework
  • ✅ Clickable badges link to full journal page
iFrame Embed Code:
Limitations:
  • ⚠️ Display-only (scores not clickable due to iframe constraints)
  • ⚠️ May have SEO limitations
  • ⚠️ Potential CORS/CSP issues on some websites
Preview:
Indexings
scopus ncbi ulakbim sci
Short Name lung cancer
Abbreviated Name lung cancer
ISSN 1872-8332
Aim and Scope
URL http://www.elsevier.com/wps/find/journaldescription.cws_home/505953/description#description
Author Instructions

Publications Per Year

Recent Articles (30 total)

2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project.
Beau-Faller, Michèle;Pencreach, Erwan;Leduc, Charlotte;Blons, Hélène;Merlio, Jean-Philippe;Bringuier, Pierre-Paul;de Fraipont, Florence;Escande, Fabienne;Lemoine, Antoinette;Ouafik, L'Houcine;Denis, Marc;Hofman, Paul;Lacave, Roger;Melaabi, Samia;Langlais, Alexandra;Missy, Pascale;Morin, Franck;Moro-Sibilot, Denis;Barlesi, Fabrice;Cadranel, Jacques;, ;
Vol. 140 , pp. 19-26
405 views DOI Abstract
2019
Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shoji, Fumihiro;Takeoka, Hiroaki;Kozuma, Yuka;Toyokawa, Gouji;Yamazaki, Koji;Ichiki, Masao;Takeo, Sadanori;
Vol. 136 , pp. 45-51
387 views DOI Abstract
2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<inf>10</inf> enough?
Abel, S.
Vol. 135 , pp. 169-174
376 views DOI
2019
Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society.
Rajadurai, Pathmanathan;Cheah, Phaik Leng;How, Soon Hin;Liam, Chong Kin;Annuar, Muhammad Azrif Ahmad;Omar, Norhayati;Othman, Noriah;Marzuki, Nurhayati Mohd;Pang, Yong Kek;Bustamam, Ros Suzanna Ahmad;Tho, Lye Mun;
Vol. 136 , pp. 65-73
335 views DOI Abstract
2019
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.
Reale, Maria Lucia;Chiari, Rita;Tiseo, Marcello;Vitiello, Fabiana;Barbieri, Fausto;Cortinovis, Diego;Ceresoli, Giovanni Luca;Finocchiaro, Giovanna;Romano, Gianpiero Diego;Piovano, Pier Luigi;Del Conte, Alessandro;Borra, Gloria;Verderame, Francesco;Scotti, Vieri;Nonnis, Daniela;Galetta, Domenico;Sergi, Concetta;Migliorino, Maria Rita;Tonini, Giuseppe;Cecere, Fabiana;Berardi, Rossana;Pino, Maria Simona;Martelli, Olga;Gelibter, Alain;Carta, Annamaria;Vattemi, Emanuela;Pagano, Maria;Zullo, Alessandro;Ferrari, Silvia;Rossi, Antonio;Novello, Silvia;
Vol. 140 , pp. 71-79
322 views DOI Abstract
2019
Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial
Fujimoto, D.
Vol. 134 , pp. 274-278
301 views DOI
2018
Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutations.
Kazdal, Daniel;Harms, Alexander;Endris, Volker;Penzel, Roland;Oliveira, Cristiano;Kriegsmann, Mark;Longuespée, Rémi;Winter, Hauke;Schneider, Marc A;Muley, Thomas;Pfarr, Nicole;Weichert, Wilko;Stenzinger, Albrecht;Warth, Arne;
Vol. 126 , pp. 80-88
290 views DOI Abstract
2001
Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study.
K Mattson,R Abratt,G.Velde Ten,K Krofta,D Tonelli,I Avril;K Mattson;R Abratt;G.Velde Ten;K Krofta;D Tonelli;I Avril;
Vol. 34 , pp. 21-23
290 views DOI
2020
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent
Buglione, M.
Vol. 141 , pp. 1-8
268 views DOI
2020
Covid-19 and lung cancer: A greater fatality rate?
Rogado, Jacobo;Pangua, Cristina;Serrano-Montero, Gloria;Obispo, Berta;Marino, Almudena Martín;Pérez-Pérez, Mar;López-Alfonso, Ana;Gullón, Pedro;Lara, Miguel Ángel;
Vol. 146 , pp. 19-22
259 views DOI Abstract
View All 30 Articles
41
Overall
Below Average
30
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

41.2/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.4/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

34.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.